和缓名医(医生版)-D2D医生移动协作平台

Downloads
Revenue

Description

和缓医疗是一家提供互联网医疗咨询服务的医疗服务企业,通过创新的产品和领先的技术整合提供高效率的医疗行业解决方案,专注服务医生群体,建立医生之间的移动协作平台,为广大医生和患者提供高社会价值的服务。
和缓医疗移动化解决方案通过 移动互联网+医疗 让和缓名医平台上的医生方便的相互协作,可实现移动会诊(一对一)、多学科会诊(MDT)、影像会诊、病理会诊、视频会诊、远程查房、手术指导、专家出诊等业务。相比于传统的视频实时会诊方式而言,大大提高了时间利用效率,短短1-2天内即可收到专家回复,还可以自主选择全国知名三甲医院权威科室的资深医师得到专业诊疗意见,有利于稳固医院的名誉和影响力。
患者在当地医院就近就医,由其主治医生通过iPad APP、手机APP、微信发起会诊,和缓平台专家进行远程指导。让患者获取最优诊疗方案,安心在当地医院治疗。
和缓医疗移动化解决方案摆脱了实时时间和医院地点的限制,有效利用碎片化时间,大大提高了服务效率,节约了医生宝贵的时间,降低了患者的综合成本,提高了医院的整体收治率,平衡了医疗资源分布不均的现状,让广大的医生和患者群体都能受益。
我们秉承信义为先的理念,坚持诚信守义。平衡医疗资源、降低患者负担、提高医疗质量、促进技术发展,从而不断创造更大的社会价值,实现延长人类寿命的理想。
Hide Show More...

Screenshots

和缓名医(医生版) FAQ

  • Is 和缓名医(医生版) free?

    Yes, 和缓名医(医生版) is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is 和缓名医(医生版) legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does 和缓名医(医生版) cost?

    和缓名医(医生版) is free.

  • What is 和缓名医(医生版) revenue?

    To get estimated revenue of 和缓名医(医生版) app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in Italy yet.
Ratings History

和缓名医(医生版) Reviews

No Reviews in Italy
App doesn't have any reviews in Italy yet.

Store Rankings

Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet

和缓名医(医生版) Competitors

Name
惠每医生
医生在线执业的必备应用
大专家医生版
CSCO
易加医医生端-收治随访肿瘤患者
肿瘤专科医生的移动助手
海心医生
肿瘤指南者医生端
乐问医学
乐问医学-做大数据+AI与生命科学的链接者
智连星医
邻客医生(专业版)
39互联网医院医生版

和缓名医(医生版) Installs

Last 30 days

和缓名医(医生版) Revenue

Last 30 days

和缓名医(医生版) Revenue and Downloads

Gain valuable insights into 和缓名医(医生版) performance with our analytics.
Sign up now to access downloads, revenue, and more.
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.